Patient Preferences for Treatments of Rheumatoid Arthritis: A Discrete Choice Experiment Evaluating Preference for Novel Neuroimmune Modulation Devices.

ABSTRACT: Despite broadening treatment options for rheumatoid arthritis (RA), challenges and unmet needs remain. This study aimed to characterize patient preferences with current pharmacologic treatments and impressions of an implantable neuroimmune modulation device. A patient survey was conducted, combined with a discrete choice experiment that included 12 choice sets, containing a device profile and drug profile, featuring 8 attributes specific to each. In total, 354 completed surveys were included, 74% female, 79% <60 years, stratified into Biologic Naïve (n = 103); Biologic-Experienced-I (n = 151); and Biologic-Experienced-II (n = 100). Lack of efficacy was the primary reason for treatment discontinuation of conventional disease-modifying antirheumatic drugs (DMARDs) and bi

SUBMITTER: Curtis JR 

PROVIDER: S-EPMC12833173 | biostudies-literature | 2026

REPOSITORIES: biostudies-literature